Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Process Allows Manipulation of Parasite Surface Coating

By LabMedica International staff writers
Posted on 02 Jun 2009
Molecular microbiologists have used the protozoan parasite Leishmania major as a model system while developing a novel method for control of lipophosphoglycan (LPG) synthesis. More...
Lipophosphoglycan is a class of glycosyl phosphatidylinositol attached to a large polysaccharide structure that coats the surfaces of many parasitic protozoa. In Leishmania, this coat helps the parasite invade host cells while avoiding the host's immune response. It may also help in protecting against antimicrobial drugs.

In the May 5, 2009, issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS), investigators from the Washington University School of Medicine (St. Louis, MO, USAu) described a system for inducible expression of LPG, applying a novel protein-based system that allowed controlled degradation of a key LPG biosynthetic enzyme, UDP-galactopyranose mutase (UGM). This methodology relied on a mutated FK506-binding protein (FKBP) destabilizing domain (dd) fused to UGM. In the absence of rapamycin analogs, such as Shld1, the dd domain was destabilized, leading to proteasomal degradation of the enzyme, whereas drug treatment conferred stabilization. The concentration of rapamycin analog in the system determined to what extent UGM was degraded, which, in turn, determined how much LPG was synthesized.

"Leishmania's carbohydrate coat is important to the parasite's survival when it infects sand flies, the insects that transmit it, and in the early stages of human infections,” said senior author Dr. Stephen Beverley, professor of molecular microbiology at Washington University School of Medicine. "By manipulating the coat's presence, we hope to learn more about how it helps the parasite survive and potentially provide new targets for drug development. This opens up many new doors to studying Leishmania, because we have not previously had a way to manipulate the parasite in such a rapid and direct fashion. We are currently implanting this tuning system in several interesting proteins and using it to further study the carbohydrate coat.”

Related Links:
Washington University School of Medicine




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.